NPI: 1356319859 · ORLANDO, FL 32806 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/09/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/09/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,736 | $2.51M |
| 2019 | 32,350 | $3.29M |
| 2020 | 32,031 | $4.07M |
| 2021 | 21,664 | $2.25M |
| 2022 | 11,047 | $1.93M |
| 2023 | 2,637 | $403K |
| 2024 | 532 | $42K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 40,459 | 1,883 | $4.68M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 33,818 | 2,329 | $4.10M |
| J1270 | Injection, doxercalciferol, 1 mcg | 23,419 | 1,609 | $2.51M |
| A4657 | Syringe, with or without needle, each | 5,234 | 1,882 | $1.18M |
| J1756 | Injection, iron sucrose, 1 mg | 7,485 | 1,333 | $612K |
| 85041 | 2,081 | 1,312 | $248K | |
| 85048 | 2,078 | 1,310 | $247K | |
| 82728 | 1,758 | 1,103 | $203K | |
| 83540 | 1,792 | 1,114 | $188K | |
| 83970 | 1,609 | 1,050 | $188K | |
| 83550 | 1,787 | 1,113 | $187K | |
| 82108 | 630 | 433 | $70K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 315 | 184 | $37K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 293 | 188 | $26K |
| 82607 | 159 | 108 | $10K | |
| 90674 | 41 | 33 | $7K | |
| G0008 | Administration of influenza virus vaccine | 21 | 17 | $4K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 18 | 13 | $0.00 |